Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms
Circulation · 04.04.2023 · 147 (14) · 1079-1096
DOI: 10.1161/circulationaha.122.060573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 04.04.2023. Verfasst von Tyler W Benson und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (T.W.B., K.A.C., T.M.C., C.W.-L., S.F., H.M.R., M. Brooks, M.T., A.P.O.), University of Cincinnati College of Medicin…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Aortic Aneurysm, Abdominal. Die Arbeit wurde bisher 170-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Large-scale human and mechanistic mouse studies indicate a strong relationship between the microbiome-dependent metabolite trimethylamine N-oxide (TMAO) and several cardiometabolic diseases. This study aims to investigate the role of TMAO in the pathogenesis of abdominal aortic aneurysm (AAA) and target its parent microbes as a potential pharmacological intervention.
Methods
TMAO and choline metabolites were examined in plasma samples, with associated clinical data, from 2 independent patient cohorts (N=2129 total). Mice were fed a high-choline diet and underwent 2 murine AAA models, angiotensin II infusion in low-density lipoprotein receptor–deficient ( Ldlr −/− ) mice or topical porcine pancreatic elastase in C57BL/6J mice. Gut microbial production of TMAO was inhibited through broad-spectrum antibiotics, targeted inhibition of the gut microbial choline TMA lyase (CutC/D) with fluoromethylcholine, or the use of mice genetically deficient in flavin monooxygenase 3 ( Fmo3 −/− ). Finally, RNA sequencing of in vitro human vascular smooth muscle cells and in vivo mouse aortas was used to investigate how TMAO affects AAA.
Results
Elevated TMAO was associated with increased AAA incidence and growth in both patient cohorts studied. Dietary choline supplementation augmented plasma TMAO and aortic diameter in both mouse models of AAA, which was suppressed with poorly absorbed oral broad-spectrum antibiotics. Treatment with fluoromethylcholine ablated TMAO production, attenuated choline-augmented aneurysm initiation, and halted progression of an established aneurysm model. In addition, Fmo3 −/− mice had reduced plasma TMAO and aortic diameters and were protected from AAA rupture compared with wild-type mice. RNA sequencing and functional analyses revealed choline supplementation in mice or TMAO treatment of human vascular smooth muscle cells–augmented gene pathways associated with the endoplasmic reticulum stress response, specifically the endoplasmic reticulum stress kinase PERK.
Conclusions
These results define a role for gut microbiota–generated TMAO in AAA formation through upregulation of endoplasmic reticulum stress–related pathways in the aortic wall. In addition, inhibition of microbiome-derived TMAO may serve as a novel therapeutic approach for AAA treatment where none currently exist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine (T.W.B., K.A.C., T.M.C., C.W.-L., S.F., H.M.R., M. Brooks, M.T., A.P.O.), University of Cincinnati College of Medicine, OH.
- Division of Cardiovascular Health & Disease (T.W.B., K.A.C., T.M.C., C.W.-L., S.F., H.M.R., M. Brooks, M.T., A.P.O.), University of Cincinnati College of Medicine, OH.
- Pathobiology and Molecular Medicine Graduate Program (K.A.C., T.M.C., C.W.-L., H.M.R., M.T., A.P.O.), University of Cincinnati College of Medicine, OH.
- Department of Cardiovascular and Metabolic Sciences, Learner Research Institute (X.S.L., Z.W., R.N.H., R.C.S., J.A.B., N.S., R.B., A.A., C.P., W.H.W.T., S.J.C., J.M.B., S.L.H.), Cleveland Clinic, OH.
- Center for Microbiome & Human Health (X.S.L., Z.W., J.A.B., N.S., W.H.W.T., J.M.B., S.L.H.), Cleveland Clinic, OH.
- Department of Environmental Health (T.S.), University of Cincinnati College of Medicine, OH.
ORCID-Profile: Xinmin S Li, Zeneng Wang, Robert N Helsley, Taylor M Coughlin, Caris Wadding-Lee, Salma Fleifil, Timothy Stone, Martin Björck, Rohan Bhandari, W H Wilson Tang, Michael Tranter, Scott J Cameron, Stanley L Hazen, A Phillip Owens
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Benson, T. W., Conrad, K. A., Li, X. S., Wang, Z., Helsley, R. N., Schugar, R. C., Coughlin, T. M., Wadding-Lee, C., Fleifil, S., Russell, H. M., Stone, T., Brooks, M., Buffa, J. A., Mani, K., Björck, M., Wanhainen, A., Sangwan, N., Biddinger, S., Bhandari, R., …, & Owens, A. P. (2023). Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms. Circulation, 147(14), 1079-1096. https://doi.org/10.1161/circulationaha.122.060573
Vancouver
Benson TW, Conrad KA, Li XS, Wang Z, Helsley RN, Schugar RC, et al. Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms. Circulation. 2023;147(14):1079-1096. doi:10.1161/circulationaha.122.060573
BibTeX
@article{Benson2023,
author = {Benson, Tyler W and Conrad, Kelsey A and Li, Xinmin S and Wang, Zeneng and Helsley, Robert N and Schugar, Rebecca C and Coughlin, Taylor M and Wadding-Lee, Caris and Fleifil, Salma and Russell, Hannah M and Stone, Timothy and Brooks, Michael and Buffa, Jennifer A and Mani, Kevin and Björck, Martin and Wanhainen, Anders and Sangwan, Naseer and Biddinger, Sudha and Bhandari, Rohan and Ademoya, Akiirayi and Pascual, Crystal and Tang, W H Wilson and Tranter, Michael and Cameron, Scott J and Brown, J Mark and Hazen, Stanley L and Owens, A Phillip},
title = {Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms},
journal = {Circulation},
year = {2023},
volume = {147},
number = {14},
pages = {1079--1096},
doi = {10.1161/circulationaha.122.060573}
}
EUVIMED